Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.71 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29392370 | 0.96 | TDP1 (0.76) | TDP1NPC1RAB9ATSHRLMNA | |
| SCHEMBL15402 | 0.96 | TDP1 (0.76) | TDP1NPC1RAB9ATSHRLMNA | |
| Ammonia Solution, Strong SCHEMBL27682254 | 0.95 | TDP1 (0.73) | TDP1NPC1RAB9ATSHRLMNA | |
| Propene SCHEMBL4194179 | 0.90 | TDP1 (0.63) | TDP1NPC1RAB9ATSHRLMNA | |
| Propene SCHEMBL83388 | 0.90 | TDP1 (0.63) | TDP1NPC1RAB9ATSHRLMNA | |
| Trimethylammonium SCHEMBL29142303 | 0.90 | TDP1 (0.67) | TDP1NPC1RAB9ATSHRLMNA | |
| Ethylene Glycol SCHEMBL432445 | 0.89 | TDP1 (0.76) | TDP1NPC1RAB9ATSHRLMNA | |
| Glycerin SCHEMBL22574599 | 0.87 | TDP1 (0.63) | TDP1NPC1RAB9ATSHRLMNA | |
| Benzophenone SCHEMBL28261937 | 0.87 | TDP1 (0.63) | TDP1NPC1RAB9ATSHRLMNA | |
| SCHEMBL30416074 | 0.87 | TDP1 (0.85) | TDP1NPC1RAB9ATSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1683 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119925175-A | Zirconia ceramic material suitable for photocuring additive manufacturing and method for preparing restoration | 杭州而然科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119843485-A | Preparation method and application of composite material | 武汉工程大学 | 2025-04-18 | — | — | CN | claimed |
| CN-119823571-A | Ultraviolet-resistant/salt-fog-resistant polyamide composite material and preparation method thereof | 古道尔材料科技(滁州)有限公司 | 2025-04-15 | — | — | CN | claimed |
| US-20250114497-A1 | SKIN COMPOSITION | MARUHO CO., LTD. (JP) | 2025-04-10 | — | — | US | claimed |
| WO-2024139383-A1 | PREPARATION METHOD FOR COATING SOLUTION, AND DRUG BALLOON FOR NON-VASCULAR INTERVENTION AND PREPARATION METHOD THEREFOR | 微创优通医疗科技（上海）有限公司 | 2024-07-04 | — | — | WO | claimed |
| WO-2024139384-A1 | DRUG BALLOON DILATATION CATHETER FOR NON-VASCULAR INTERVENTION | 微创优通医疗科技（上海）有限公司 | 2024-07-04 | — | — | WO | claimed |
| CN-118146447-A | Preparation method and application of ionic gel electrolyte for lithium metal battery | 河北工业大学 | 2024-06-07 | — | — | CN | claimed |
| CN-118059071-A | Colchicine-containing transdermal patch, and preparation method and application thereof | 北京德默高科医药技术有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-116723865-A | External composition | 花王株式会社 | 2023-09-08 | — | — | CN | claimed |
| CN-115444773-B | Anti-inflammatory repair composition containing glycol salicylate, and preparation method and application thereof | 陕西畅想制药有限公司 | 2023-09-05 | — | — | CN | claimed |
| WO-2007137128-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | MARY KAY INC. (US) | 2007-11-29 | — | — | WO | claimed |
| US-20070269391-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | MARY KAY, INC. (US) | 2007-11-22 | — | — | US | claimed |
| WO-2007059076-A2 | PEPTIDE-BASED ORGANIC SUNSCREENS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-24 | — | — | WO | claimed |
| US-20070110686-A1 | Peptide-based organic sunscreens | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-17 | — | — | US | claimed |
| WO-2007038733-A1 | METHOD FOR ENHANCING EFFECTS OF COLORANTS AND CONDITIONERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-04-05 | — | — | WO | claimed |
| US-20070067924-A1 | Method for enhancing effects of colorants and conditioners | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-03-29 | — | — | US | claimed |
| WO-2006099687-A1 | SUNSCREEN AEROSOL SPRAY | ENSIGN LABORATORIES PTY LTD (AU) | 2006-09-28 | — | — | WO | claimed |
| US-20060134095-A1 | Antioxidative composition and composition for external use | VITAMIN C60 BIORESEARCH CORPORATION (JP) | 2006-06-22 | — | — | US | claimed |
| CN-1717224-A | Therapeutic compositions | POLYMERIX CORP (US) | 2006-01-04 | — | — | CN | claimed |
| EP-1595936-A1 | ANTIOXIDATIVE COMPOSITION AND COMPOSITION FOR EXTERNAL USE | MITSUBISHI CORPORATION (JP) | 2005-11-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070269391-A1 | GLYCERYL AND GLYCOL ACID COMPOUNDS | GLA, GK, UNG | TDP1 892/4885NPC1 3423/4885RAB9A 1927/4885 |
| US-20060134095-A1 | Antioxidative composition and composition for external use | GPX4, GPX1, SOD1 | TDP1 3683/4885NPC1 1691/4885RAB9A 3841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.